N. Vanbaren et al., PRAME, A GENE ENCODING AN ANTIGEN RECOGNIZED ON A HUMAN-MELANOMA BY CYTOLYTIC T-CELLS, IS EXPRESSED IN ACUTE-LEUKEMIA CELLS, British Journal of Haematology, 102(5), 1998, pp. 1376-1379
Gene PRAME was found to encode an antigen recognized on a human melano
ma cell Line by an autologous cytolytic T-lymphocyte clone. This gene
is expressed at a high level in a very large fraction of tumours, such
as melanomas, non-small-cell lung carcinomas, sarcomas, head and neck
tumours and renal carcinomas. It is therefore a candidate for tumour
immunotherapy even though some low expression is found in certain norm
al tissues. We tested by RT-PCR the expression of PRAME on more than 2
50 bone marrow or blood samples from patients with a haematological ma
lignancy, Approximately 25% of the acute leukaemia samples were positi
ve, Remarkably, all acute myeloblastic leukaemias that carried the chr
omosomal translocation t(8;21), which fuses the genes AML1 and ETO, ex
pressed PRAME at a high level.